Nutex Health, Inc.

NASDAQ:NUTX

Medical - Healthcare Information Services

Healthcare
$172.74 +1.94%

+$2.84 today

Market cap
$1.19B
Beta
2.06
P/E (TTM)
10.4
EPS (TTM)
$14.38
52W Low $77.21High $193.07

Volume 0.16M

Average 0.17M

NUTX Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Nutex Health, Inc.NASDAQ: NUTX

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue grows, but more slowly than its trailing trend

Q1 FY2026 revenue of $216.49M rose 2.2% year over year, behind the +41.0% change in trailing-twelve-month revenue. Sequentially, it rose 42.7% from the prior quarter. Over 3 fiscal years it compounded at +58.6% a year.

Context

  • Revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 4 analysts of $871.11M (-0.5%) for the fiscal year ending Dec 2026, a slowdown from the +82.4% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$216.49M+42.7% QoQ
Last fiscal yearDec 2025
$875.26M+82.4% YoY
LTMMar 2026
$879.95M+41.0% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2.2%-11.9%-14.1 pp
1 year+82.4%-0.5%-82.8 pp
3-year CAGR+58.6%+5.2%-53.4 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
875.26M USD
Year-over-year change
+82.4%
4-year CAGR
+27.5%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How NUTX compares with its peers on the latest reported figures

  • NUTX's LTM Mar 2026 revenue of $879.95M is the lowest of the 11 companies compared; the peer median is $6.01B.
  • Its year-over-year change of +41.0% is the 3rd highest of 11, against a peer median of +9.8%.
  • Over three fiscal years its annual growth of +58.6% compares with a peer median of +8.4%.
NUTX Competitors Peer median
Revenue for NUTX and competitors
Company Period LTM YoY 3-year CAGR
THCTenet Healthcare CorporationLTM Jun 2026$21.81B +5.4%+3.6%
CYHCommunity Health Systems, Inc.LTM Mar 2026$21.48B +69.8%+0.7%
UHSUniversal Health Services, Inc.LTM Jun 2026$18.11B +10.0%+9.0%
ARDTArdent Health Partners, LLCLTM Mar 2026$6.43B +6.7%+7.2%
EHCEncompass Health CorporationLTM Jun 2026$6.21B +9.5%+10.9%
AGLAgilon Health, Inc.LTM Mar 2026$5.82B -2.8%+35.4%
ASTHAstrana Health, Inc.LTM Mar 2026$3.53B +56.7%+40.6%
SGRYSurgery Partners, Inc.LTM Sep 2026$3.36B +2.2%+9.2%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$2.34B +11.8%+7.9%
INNVInnovAge Holding Corp.LTM Mar 2026$945.9M +13.7%+6.9%
NUTXNutex Health, Inc.LTM Mar 2026$879.95M +41.0%+58.6%
Peer median (excluding NUTX) $6.01B+9.8%+8.4%

Competitors are the stored peer set for NUTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue331.53M219.29M247.65M479.95M875.26M
Cost of Revenue152.25M203.87M212.87M283.69M430.98M
Gross Profit179.28M15.42M34.77M196.26M444.28M
Gross Margin54.1%7.0%14.0%40.9%50.8%
Research & Development285.88K0000
Selling, General & Admin5.46M20M36.07M58.56M168.66M
Operating Expenses9.02M422.02M66.55M65.64M168.66M
Depreciation & Amortization7.76M13.13M17.59M18.97M20.53M
EBITDA183.45M(394.03M)(14.58M)148.65M287.54M
EBITDA Margin55.3%-179.7%-5.9%31.0%32.9%
Operating Income170.26M(406.6M)(31.77M)130.62M275.63M
Operating Margin51.4%-185.4%-12.8%27.2%31.5%
Interest Income00000
Interest Expense6.2M12.49M16.32M19.93M22.23M
Other Income / Expenses(773.88K)(13.05M)(16.72M)(20.87M)(30.84M)
Income Before Tax169.49M(419.65M)(48.49M)109.75M244.78M
Pre-Tax Margin51.1%-191.4%-19.6%22.9%28.0%
Income Tax Expense965.73K13.09M(5.07M)14.48M64.42M
Net Income132.59M(424.78M)(45.79M)52.18M70.79M
Net Margin40.0%-193.7%-18.5%10.9%8.1%
EPS (Basic)33.55(100.50)(10.39)10.2311.13
EPS (Diluted)33.55(100.36)(10.39)9.7110.48
Weighted Avg Shares4.02M4.23M4.41M5.1M6.36M
Weighted Avg Shares (Diluted)3.95M4.23M4.41M5.1M6.76M

Nutex Health, Inc.

NASDAQ:NUTX

Intrinsic Alpha fair value

Locked

Current Price

$172.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.